Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/1998
06/23/1998US5770592 Vision defects
06/23/1998US5770571 Method and agents for inhibiting protein aging
06/23/1998US5770209 Acceleration of wound healing using connective tissue growth factor
06/23/1998US5770196 Modified antibody variable domains and therapeutic uses thereof
06/20/1998CA2225273A1 Vitronectin receptor antagonists, their preparation and their use
06/20/1998CA2225267A1 Vitronectin receptor antagonists, their preparation and their use
06/18/1998WO1998026068A1 Human apoptosis-related calcium-binding protein
06/18/1998WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025649A1 Use of low molecular weight amino alcohols in ophthalmic compositions
06/18/1998WO1998025648A2 Use of a texaphyrin in ocular diagnosis and therapy
06/18/1998WO1998025620A1 Process for manufacturing ophthalmic suspensions
06/18/1998WO1998025610A1 Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts
06/18/1998WO1998025609A1 PYRROLES AS sPLA2 INHIBITORS
06/18/1998WO1998025602A1 Glaucoma remedy
06/18/1998CA2278937A1 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
06/18/1998CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/18/1998CA2274739A1 Human apoptosis-related calcium-binding protein
06/18/1998CA2274571A1 Pyrroles as spla2 inhibitors
06/17/1998EP0847277A1 Treatment of ocular inflammatory conditions with interleukin-10
06/17/1998EP0847276A2 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
06/16/1998US5767143 Eye drops containing single polymer, pilocarpine, beta-blocking agent, carrier, having specified ph and viscosity
06/16/1998US5767102 Antisense composition and method for treatment of CMV infection
06/16/1998US5766886 Modified antibody variable domains
06/16/1998US5766610 Useful for treatment of mammalian skin and hair, rheumatism, resipiratory system disorder, cardiovascular and vision disorders
06/16/1998US5766591 Methods and compositions useful for inhibition of angiogenesis
06/16/1998US5766580 Controlled release of miotic and mydriatic drugs in the anterior chamber
06/16/1998CA2065965C Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
06/11/1998WO1998024898A2 Therapeutic composition comprising the kal protein and use of the kal protein
06/11/1998WO1998024783A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
06/11/1998WO1998024782A2 Substituted pyrimidine compounds and their use
06/11/1998WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
06/11/1998WO1998024465A1 Wound healing and treatment of fibrosis
06/11/1998WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury
06/11/1998CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998CA2274002A1 Wound healing and treatment of fibrosis
06/10/1998EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998EP0846116A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
06/10/1998CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763487 Skin disorders, cardiovascular disorders and cosmetics
06/09/1998US5763484 Metabolites of linoleic acid and a-linolenic acid
06/09/1998US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023610A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023608A1 Novel integrin receptor antagonists
06/04/1998WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023581A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/04/1998CA2272683A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272644A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272565A1 Integrin receptor antagonists
06/04/1998CA2272388A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0845268A2 Composition for treating cornea
06/03/1998EP0844875A2 Use of basic amino acids and derivatives for lowering ceramide levels
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998CN1183720A Method for treatment of macular degeneration
06/03/1998CN1183302A Eye drops contg. sodium hyaluronate and preparing method thereof
06/03/1998CA2223349A1 Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies
06/02/1998US5760084 Treating dermatological disorders
06/02/1998US5760075 Method and means for prevention and treatment of secondary cataract
06/02/1998US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998US5759532 Controlled release of miotic and myriatic drugs in the anterior chamber
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
05/1998
05/29/1998CA2222483A1 Composition for treating cornea
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022423A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/28/1998WO1998022138A1 Method for treating symptoms of diabetes
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022130A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
05/28/1998WO1998022129A1 Therapeutic agent for ophthalmic diseases
05/28/1998WO1998022101A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
05/28/1998WO1998016551A3 Variants of vascular endothelial cell growth factor having antagonistic properties
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998DE19648793A1 Neue Benzamide und deren Anwendung New benzamides and their application
05/28/1998CA2633660A1 Method for treating symptoms of diabetes
05/28/1998CA2272073A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998CA2243161A1 Use of interferon-beta to treat retinal edema
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998EP0656889B1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
05/27/1998CN1038474C Stable extended release oral dosage composition
05/26/1998US5756818 Hydrogenation; protecting; deprotecting; clathrates
05/26/1998US5756810 Process of preparing 3-nitro benzoate compounds in lower alkanol
05/26/1998US5756541 Irridiating target ocular tissue of patient with laser radiation, wherein the patient has been administered with porphyrins photoactive drugs which absorb the wavelength of the radiation, repetation of tratement increase visual acuity
1 ... 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 ... 531